Marc Tewey

Company: Exegi Pharmaceuticals

Job title: Chief Executive Officer

Seminars:

EXE-346 Live Biotherapeutic – A “Food To Drug” Conversion 1:30 pm

EXE-346 is a high dose probiotic blend intended for the treatment of excessive stool frequency in patients with an ileal pouch anal anastomosis The same formulation in a lower potency has been commercialized as a non-drug product for over 20 years under several consumer brand names The presentation will summarize the evolution of this product…Read more

day: Day One Track A (PM)